131 related articles for article (PubMed ID: 25466185)
1. Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors.
Li X; Li L; Zhou Q; Zhang N; Zhang S; Zhao R; Liu D; Jing Y; Zhao L
Bioorg Med Chem Lett; 2014 Dec; 24(24):5612-5615. PubMed ID: 25466185
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors.
Zhu L; Jin J; Liu C; Zhang C; Sun Y; Guo Y; Fu D; Chen X; Xu B
Bioorg Med Chem; 2011 May; 19(9):2797-807. PubMed ID: 21504850
[TBL] [Abstract][Full Text] [Related]
3. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton.
Liu C; Jin J; Chen L; Zhou J; Chen X; Fu D; Song H; Xu B
Bioorg Med Chem; 2012 May; 20(9):2992-9. PubMed ID: 22459212
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of novel human Pin1 inhibitors (I).
Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of novel human Pin1 inhibitors (II).
Dong L; Marakovits J; Hou X; Guo C; Greasley S; Dagostino E; Ferre R; Johnson MC; Kraynov E; Thomson J; Pathak V; Murray BW
Bioorg Med Chem Lett; 2010 Apr; 20(7):2210-4. PubMed ID: 20207139
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.
Cui G; Jin J; Chen H; Cao R; Chen X; Xu B
Bioorg Med Chem; 2018 May; 26(8):2186-2197. PubMed ID: 29576270
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
Zhao H; Cui G; Jin J; Chen X; Xu B
Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
[TBL] [Abstract][Full Text] [Related]
9. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.
Duncan KE; Dempsey BR; Killip LE; Adams J; Bailey ML; Lajoie GA; Litchfield DW; Brandl CJ; Shaw GS; Shilton BH
J Med Chem; 2011 Jun; 54(11):3854-65. PubMed ID: 21545152
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocket.
Guo C; Hou X; Dong L; Marakovits J; Greasley S; Dagostino E; Ferre R; Johnson MC; Humphries PS; Li H; Paderes GD; Piraino J; Kraynov E; Murray BW
Bioorg Med Chem Lett; 2014 Sep; 24(17):4187-91. PubMed ID: 25091930
[TBL] [Abstract][Full Text] [Related]
11. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
[TBL] [Abstract][Full Text] [Related]
12. Pin1 inhibitors: Pitfalls, progress and cellular pharmacology.
Moore JD; Potter A
Bioorg Med Chem Lett; 2013 Aug; 23(15):4283-91. PubMed ID: 23796453
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel 2-substituted 11-keto-boswellic acid heterocyclic derivatives as anti-prostate cancer agents with Pin1 inhibition ability.
Li K; Li L; Wang S; Li X; Ma T; Liu D; Jing Y; Zhao L
Eur J Med Chem; 2017 Jan; 126():910-919. PubMed ID: 27997878
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.
Ma T; Huang M; Li A; Zhao F; Li D; Liu D; Zhao L
Bioorg Med Chem Lett; 2019 Jul; 29(14):1859-1863. PubMed ID: 31103446
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity.
Huang M; Li A; Zhao F; Xie X; Li K; Jing Y; Liu D; Zhao L
Bioorg Med Chem Lett; 2018 Oct; 28(19):3187-3193. PubMed ID: 30153964
[TBL] [Abstract][Full Text] [Related]
16. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
[TBL] [Abstract][Full Text] [Related]
17. Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.
Liu T; Liu Y; Kao HY; Pei D
J Med Chem; 2010 Mar; 53(6):2494-501. PubMed ID: 20180533
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
Du L; Wang X; Cui G; Xu B
Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
[TBL] [Abstract][Full Text] [Related]
20. A reduced-amide inhibitor of Pin1 binds in a conformation resembling a twisted-amide transition state.
Xu GG; Zhang Y; Mercedes-Camacho AY; Etzkorn FA
Biochemistry; 2011 Nov; 50(44):9545-50. PubMed ID: 21980916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
